Localization of M2 muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus

Neuroscience Letters

Volumn 284, Issue 3, 2000, Pages 182-186

  Rouse, Susan T ^a   Edmunds, Sharon M ^a   Yi, Hong ^a   Gilmor, Michelle L ^a   Levey, Allan I ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoreceptor; Hippocampus; Immunocytochemistry; Muscarinic; Presynaptic; Vesicular acetylcholine transporter

Indexed keywords

MUSCARINIC M2 RECEPTOR; PRESYNAPTIC RECEPTOR; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; SYNAPTOSOME;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CARRIER PROTEINS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, ELECTRON; PRESYNAPTIC TERMINALS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 0034724784     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01011-9     Document Type: Article

References (20)

1. Behrends J.C., ten Bruggencate G. Cholinergic modulation of synaptic inhibition in the guinea pig hippocampus in vitro: excitation of GABAergic interneurons and inhibition of GABA-release. J. Neurophysiol. 69:1993;626-629.
2. Bodick N.C., Offen W.W., Levey A.I. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch. Neurol. 54:1997;465-473.
3. Bonanno O., Raiteri M. Regional selectivity of a gamma-aminobutyric acid-induced acetylcholine release sensitive to inhibitors of gamma-aminobutyric acid uptake. J. Neurochem. 48:1987;1454-1458.
4. Buckley N.J., Bonner T.I., Buckley C.M., Brann M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 35:1989;469-476.
5. Coyle J.R., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
6. Dorje F., Wess J., Lambrecht O., Tacke R., Mutschler E., Brann M.R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 256:1991;727-733.
7. Farlow M., Gracon S.I., Hershey L.A., Lewis K.W., Sadowsky C.H., Dolan-Ureno J. A controlled trial of tacrine in Alzheimer's disease. J. Am. Med. Assoc. 268:1992;2523-2529.
8. Gilmor M.L., Nash N.R., Roghani A., Edwards R.H., Yi H., Hersch S.M., Levey A.I. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J. Neurosci. 16:1996;2179-2190.
9. 2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience. 82:1998;355-376.
10. 2 muscarinic acetylcholine receptor in the basal forebrain of the rat. J. Comp. Neurol. 351:1995;339-356.
11. Levey A.I., Edmunds S.M., Koliatsos V., Wiley R.G., Heilman C.J. Expression of m1m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J. Neurosci. 15:1995;4077-4092.
12. Marchi M., Raiteri M. Interaction acetylcholine-glutamate in rat hippocampus: involvement of the two subtypes of M-2 muscarinic receptors. J. Pharmacol. Exp. Ther. 248:1989;1255-1260.
13. McKinney M., Miller J.H., Aagaard P.J. Pharmacological characterization of the rat hippocampal muscarinic autoreceptor. J. Pharmacol. Exp. Ther. 264:1993;74-78.
14. 3H] acetylcholine release from rat hippocampal slices. J. Pharmacol. Exp. Ther. 244:1988;213-217.
15. Raiteri M., Marchi M., Maura G., Bonanno G. Presynaptic regulation of acetylcholine release in the CNS. Cell Biol. Int. Rep. 13:1989;1109-1118.
16. 3 receptors. Br. J. Pharmacol. 99:1990;753-761.
17. 2: diverse functional implications of differential synaptic localization, Life Sci. 60:1997;1031-1038.
18. Stillman M.J., Shukitt-Hale B., Kong R.M., Levy A., Lieberman H.R. Elevation of hippocampal extracellular acetylcholine levels by methoctramine. Brain Res. Bull. 32:1993;385-389.
19. Vickroy T.W., Malphurs W.L., Defiebre N.C. Absence of receptor reserve at hippocampal muscarinic autoreceptors which inhibit stimulus-dependent acetylcholine release. J. Pharmacol. Exp. Ther. 267:1993;1198-1204.
20. 2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience. 47:1992;367-393.